Amarin Corporation PLC (AMRN)

5.46
-0.26(-4.55%)
  • Volume:
    2,649,629
  • Bid/Ask
    5.45/5.46
  • Day's Range
    5.36 - 5.85

AMRN Overview

Prev. Close
5.46
Day's Range
5.36 - 5.85
Revenue
614.06M
Open
5.82
52 wk Range
3.36 - 15.57
EPS
-0.05
Volume
2,649,629
Market Cap
2.25B
Dividend (Yield)
N/A (N/A)
Average Volume (3m)
8,163,234
P/E Ratio
N/A
Beta
2.47
1-Year Change
-64.29%
Shares Outstanding
393,635,467
Next Earnings Date
04 May 2021
What is your sentiment on Amarin Corporation PLC?
or
Vote to see community's results!

Amarin Corporation PLC News

Amarin Corporation PLC Analysis

    • BySeeking Alpha-

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Amarin Corporation PLC Company Profile

Amarin Corporation PLC Company Profile

Employees
965

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.